Perha Pharmaceuticals has been selected by the European Commission under the European Innovation Council (EIC) Accelerator Programme for the development... View Article
Author Archives for Adeline Chauvigné
Perha Pharmaceuticals is a laureate of the European Innovation Council (EIC) Accelerator Programme and could receive an €8 M in funding for the development of its lead candidate Leucettinib-21
17 May 2024Perha Pharmaceuticals has been selected by the European Commission under the European Innovation Council (EIC) Accelerator Programme for the development... View Article
Pherecydes Pharma announces a first registration of its phagogram as an in vitro diagnostic test in accordance with EC Directives
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the registration... View Article
Pherecydes Pharma announces a first registration of its phagogram as an in vitro diagnostic test in accordance with EC Directives
17 May 2024Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the registration... View Article
Naobios x GenSensor: a partnership for bioprocess optimization
A partnership between three members of Atlanpole Biotherapies: Naobios, Clean Biologics and GenSensor. The collaboration aims at bioprocess optimization through joint bioproduction expertise. Two companies providing expert... View Article
Naobios x GenSensor: a partnership for bioprocess optimization
17 May 2024A partnership between three members of Atlanpole Biotherapies: Naobios, Clean Biologics and GenSensor. The collaboration aims at bioprocess optimization through joint bioproduction expertise. Two companies providing expert... View Article
VitaDX signs a strategic partnership with the XPath group for the use of its VisioCyt® software solution
XPath, a group of medical specialists in pathological anatomy and cytology, a player in this medical specialty that has made... View Article
VitaDX signs a strategic partnership with the XPath group for the use of its VisioCyt® software solution
17 May 2024XPath, a group of medical specialists in pathological anatomy and cytology, a player in this medical specialty that has made... View Article
AbolerIS Pharma selected for the HealthTech For Care Innovation Award
The HealthTech For Care Innovation Award will be presented for the first time at the HealthTech Innovation Days on October... View Article
AbolerIS Pharma selected for the HealthTech For Care Innovation Award
17 May 2024The HealthTech For Care Innovation Award will be presented for the first time at the HealthTech Innovation Days on October... View Article
Valneva reports further positive phase 3 immunogenicity and the first heterologous booster tesults for its inactivated, adjuvanted COVID-19 vaccine VLA2001
Valneva, a specialty vaccine company, reported further positive Phase 3 results for its inactivated, adjuvanted COVID-19 vaccine VLA2001. Additional readouts... View Article
Valneva reports further positive phase 3 immunogenicity and the first heterologous booster tesults for its inactivated, adjuvanted COVID-19 vaccine VLA2001
17 May 2024Valneva, a specialty vaccine company, reported further positive Phase 3 results for its inactivated, adjuvanted COVID-19 vaccine VLA2001. Additional readouts... View Article
New member | Rouen Normandy University
Rouen Normandy University, which employs more than 2500 persons, is a multidisciplinary university, hosting approximately 35,000 students, nearly a quarter... View Article
New member | Rouen Normandy University
17 May 2024Rouen Normandy University, which employs more than 2500 persons, is a multidisciplinary university, hosting approximately 35,000 students, nearly a quarter... View Article
New member | University of Orléans
The University of Orléans is characterized by its multidisciplinary nature. It has 3 Training and Research Units, 1 university engineering... View Article
New member | University of Orléans
17 May 2024The University of Orléans is characterized by its multidisciplinary nature. It has 3 Training and Research Units, 1 university engineering... View Article
Valneva confirms WHO recommendations for its inactivated COVID-19 vaccine
Valneva, a specialty vaccine company, confirms that the World Health Organization (WHO) has issued recommendations for use of the Company’s... View Article
Valneva confirms WHO recommendations for its inactivated COVID-19 vaccine
17 May 2024Valneva, a specialty vaccine company, confirms that the World Health Organization (WHO) has issued recommendations for use of the Company’s... View Article
Framatome announces investment in Global Morpho Pharma for nuclear medicine development
Framatome announced that it acquired a minority stake in Global Morpho Pharma. With this investment, Framatome strengthens its activities serving... View Article
Framatome announces investment in Global Morpho Pharma for nuclear medicine development
17 May 2024Framatome announced that it acquired a minority stake in Global Morpho Pharma. With this investment, Framatome strengthens its activities serving... View Article